Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
Open Access
- 1 September 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 135 (3) , 2063-2068
- https://doi.org/10.4049/jimmunol.135.3.2063
Abstract
Elucidation of the interactions between C5a and granulocytes is central to understanding the role of C5a in inflammation. In this study, interactions between C5a and PMN have been studied at two levels. Binding of human C5a to intact human cells has been characterized by using the radiolabeled ligand 125I-C5a. Binding is shown to be reversible, saturable, and to reach equilibrium in 60 to 90 min at 0 degrees C. Results show high affinity C5a binding sites with Kd = 2 X 10(-9) M and a range of 50,000 to 113,000 binding sites per PMN. These values for C5a receptors are comparable with the number of fMLP and LTB4 receptors on PMN. Binding of C5a to PMN fails to reach equilibrium at 37 degrees C because there is an irreversible loss of available surface receptors caused by an active internalization of the ligand-receptor complex. Interactions between C5a and human PMN were characterized further by cross-linking experiments, with the use of ethylene glycol bis succinimidylsuccinate (EGS). Cross-linking of 125I-C5a to intact PMN followed by subcellular fractionation revealed a single radioactive band present only in the plasma membrane fraction and visualized by autoradiography. Similar experiments resulted in a covalent linkage between 125I-C5a and a component in the isolated plasma membrane of PMN. The covalent complex containing C5a and a putative receptor has been visualized by autoradiography as a single 60,000 Mr complex on SDS-PAGE. The complex is not present when experiments are performed in the presence of excess unlabeled C5a or in the absence of EGS. Therefore, the putative receptor for C5a on human neutrophils is estimated to be approximately 48,000 Mr, assuming contribution of 12,000 to 13,000 daltons by the ligand 125I-C5a.This publication has 26 references indexed in Scilit:
- Platelet-serotonin release by C3a and C5a: two independent pathways of activation.The Journal of Immunology, 1981
- Cross-linking studies of cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductaseBiochemistry, 1980
- ENHANCED VASCULAR-PERMEABILITY AND HEMORRHAGE-INDUCING ACTIVITY OF RABBIT C5ADES ARG - PROBABLE ROLE OF POLYMORPHONUCLEAR LEUKOCYTE LYSOSOMES1980
- Aggregation of Leukocytes Induced by the Complement-Derived Peptides C3a and C5a and by Three Synthetic Formyl-Methionyl PeptidesInternational Archives of Allergy and Immunology, 1980
- Biological effects of the human complement fragments C5a and C5ades Arg on neutrophil functionImmunopharmacology, 1980
- Receptor-mediated uptake and degradation of 125I-chemotactic peptide by human neutrophils.Journal of Biological Chemistry, 1979
- Modulating Influence of Chemotactic Factor-Induced Cell Adhesiveness on Granulocyte FunctionJournal of Clinical Investigation, 1979
- A modified method for chemotaxis under agaroseJournal of Immunological Methods, 1979
- Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.Proceedings of the National Academy of Sciences, 1978
- Induction of platelet aggregation by the complement-derived peptides C3a and C5aNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976